b'
ICD generator change, less is more in VT management, co-morbidity in HF, and SGLT2i after AF ablation are the topics discussed by John Mandrola, MD, in this week\\u2019s podcast.
This podcast is intended for healthcare\\xa0professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I. ICD Gen Change
- Patients\\u2019 Perspectives Regarding Generator Exchanges of Implantable Cardioverter Defibrillators https://www.ahajournals.org/doi/10.1161/CIRCOUTCOMES.122.009827
- DEFINITE https://www.nejm.org/doi/10.1056/nejmoa033088
- SCD-HeFT https://www.nejm.org/doi/full/10.1056/nejmoa043399
- DANISH https://www.nejm.org/doi/10.1056/NEJMoa1608029
- Poole and colleagues; 11-year follow-up of \\xa0SCD-HeFT https://doi.org/10.1016/j.jacc.2020.05.061
- Editorial \\u2013 Howell/Stecker https://www.ahajournals.org/doi/10.1161/CIRCOUTCOMES.123.010266
II. VT Therapy
Crossed Wires: Ischemia Testing and Monomorphic VT Storm
https://www.medscape.com/viewarticle/995401
- Cleveland Clinic Study
\\xa0\\xa0https://doi.org/10.1016/j.jacep.2023.04.030
III. Co-Morbidity in HF
- Hospital admissions in the last year of life of patients with heart failure
\\xa0\\xa0https://doi.org/10.1093/ehjqcco/qcad047
- Four Horsemen of Apocalypse Lecture
\\xa0\\xa0http://www.louisvillelectures.org/imblog/2017/10/5/whw8sf0m1k0wi6lm6kvjsx4nxzzjg5
IV. SGLT2i After Ablation for AF
SGLT2 Inhibitors Curb AF Post-Ablation Recurrences in Diabetes
\\xa0\\xa0https://www.medscape.com/viewarticle/995415
- Observational Study \\u2013 Abu-Qaoud et al
\\xa0\\xa0https://www.jacc.org/doi/full/10.1016/j.jacep.2023.06.008
- Meta-analysis SGLT2i and AF
\\xa0\\xa0https://www.ahajournals.org/doi/full/10.1161/JAHA.121.022222
You may also like:
Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine
https://www.medscape.com/features/public/machine
The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.
https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact news@medscape.net
'